
AngioDynamics ANGO
$ 11.03
0.0%
Quarterly report 2026-Q1
added 04-02-2026
AngioDynamics DPO Ratio 2011-2026 | ANGO
Annual DPO Ratio AngioDynamics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96.2 | 95.6 | 76 | 57.8 | 52.7 | 67.2 | 72.7 | 34.4 | 38.1 | 31.7 | 48 | 68.8 | 51.7 | 111 | 46.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 111 | 31.7 | 63.2 |
Quarterly DPO Ratio AngioDynamics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75.3 | 87.8 | - | 89.5 | 91.4 | 102 | - | 84.5 | 73.4 | 77.1 | - | 79.8 | 72.3 | 66.6 | 28.4 | 59 | 56.7 | 52.4 | 24 | 49.8 | 42 | 43.8 | 53.5 | 49.1 | 55.9 | 65.1 | 73.2 | 69.3 | 56.3 | 53.3 | 34 | 41.9 | 40.7 | 36.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 102 | 24 | 60.8 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
72.6 | $ 60.59 | 0.35 % | $ 12.1 B | ||
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
7.87 | $ 115.9 | 1.52 % | $ 3.71 B | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
ICU Medical
ICUI
|
39.2 | $ 122.44 | -0.45 % | $ 3.02 B | ||
|
Repro Med Systems
KRMD
|
46.1 | $ 3.98 | - | $ 184 M | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Intuitive Surgical
ISRG
|
23.9 | $ 429.39 | 0.31 % | $ 153 B | ||
|
LeMaitre Vascular
LMAT
|
13.9 | $ 99.56 | 0.06 % | $ 2.25 B | ||
|
Alcon
ALC
|
63.6 | $ 64.57 | 0.85 % | $ 40.4 B | ||
|
Masimo Corporation
MASI
|
84.4 | $ 178.4 | 0.03 % | $ 9.51 B | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
91.4 | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
54.2 | $ 23.63 | -0.92 % | $ 3.97 B | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
195 | $ 6.35 | -1.24 % | $ 53.9 K | ||
|
Haemonetics Corporation
HAE
|
41.9 | $ 57.27 | 0.32 % | $ 2.88 B | ||
|
STAAR Surgical Company
STAA
|
37 | $ 32.26 | 0.78 % | $ 1.6 B | ||
|
STERIS plc
STE
|
31.8 | $ 215.24 | -0.41 % | $ 21.2 B | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
67.2 | $ 143.35 | 0.83 % | $ 6.94 B | ||
|
Teleflex Incorporated
TFX
|
47.7 | $ 130.44 | 0.12 % | $ 5.82 B | ||
|
InfuSystem Holdings
INFU
|
59.7 | $ 8.61 | -0.29 % | $ 178 M | ||
|
Microbot Medical
MBOT
|
34.9 | $ 1.87 | 1.08 % | $ 85.6 M | ||
|
Milestone Scientific
MLSS
|
66.3 | $ 0.34 | 0.61 % | $ 27.9 M | ||
|
Merit Medical Systems
MMSI
|
30.3 | $ 61.9 | -1.05 % | $ 3.66 B | ||
|
Utah Medical Products
UTMD
|
17.8 | $ 63.24 | -0.72 % | $ 205 M | ||
|
West Pharmaceutical Services
WST
|
45.7 | $ 300.72 | 0.19 % | $ 21.7 B | ||
|
Pulse Biosciences
PLSE
|
1.51 K | $ 25.77 | -4.91 % | $ 1.74 B | ||
|
DENTSPLY SIRONA
XRAY
|
53.7 | $ 10.2 | -2.26 % | $ 2.03 B | ||
|
Retractable Technologies
RVP
|
46 | $ 0.69 | 0.01 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
35.4 | $ 58.65 | - | $ 193 M | ||
|
Predictive Oncology
POAI
|
7.25 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
25.9 | $ 20.67 | -1.85 % | $ 987 M | ||
|
Stereotaxis
STXS
|
124 | $ 1.9 | -2.31 % | $ 173 M | ||
|
Baxter International
BAX
|
45.6 | $ 17.55 | -1.35 % | $ 9 B | ||
|
ResMed
RMD
|
34.9 | $ 204.17 | 0.8 % | $ 29.8 B | ||
|
AtriCure
ATRC
|
68.7 | $ 29.05 | 3.2 % | $ 1.39 B | ||
|
Harvard Bioscience
HBIO
|
42 | $ 5.32 | -3.6 % | $ 236 M | ||
|
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 144.13 | -0.27 % | $ 41.5 B | ||
|
Nephros
NEPH
|
39.8 | $ 3.24 | -2.99 % | $ 34.4 M | ||
|
OraSure Technologies
OSUR
|
40.1 | $ 2.98 | 1.02 % | $ 219 M | ||
|
Repligen Corporation
RGEN
|
32.2 | $ 105.01 | 1.58 % | $ 5.91 M |